Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Immunology Letters|December 1, 1989
Functionally different HTLV I-infected T cell lines with the same phenotype derived from a patient with melanomaM Sivanandham, B Mukherji
Immunological Reviews|August 1, 1990
T-cell clones that react against autologous human tumorsB Mukherji, N G Chakraborty, M Sivanandham
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinomaN Tanaka, M Sivanandham, M K Wallack
International Journal of Radiation Oncology, Biology, Physics|November 1, 1987
Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton's lymphoma associated antigen (anti-DLAA)M Udayachander, A Meenakshi, R Muthiah, et al.
The Mount Sinai Journal of Medicine, New York|May 1, 1992
Active specific immunotherapy with vaccinia melanoma oncolysateM K Wallack, S D Scoggin, M Sivanandham
Immunology Letters|May 1, 1991
Clonal expansion of T cells following in vitro stimulation with autologous melanoma cells and interleukin-2 studied by molecular analysis of a T cell receptorM Sivanandham, N G Chakraborty, G R Robbins, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1994
Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis modelM Sivanandham, S D Scoggin, N Tanaka, et al.
Annals of Plastic Surgery|January 1, 1992
Prospects for gene therapy and lymphokine therapy for metastatic melanomaM Sivanandham, S D Scoggin, R G Sperry, et al.
Annals of Plastic Surgery|January 1, 1992
Active specific adjuvant immunotherapy with vaccinia melanoma oncolysateS D Scoggin, M Sivanandham, R G Sperry, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 1998
Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic miceM Sivanandham, P Shaw, S F Bernik, et al.
Pageof 2